SEER - NASDAQ

Seer, Inc.

SEER·NASDAQ

$1.87

-1.1%

HealthcareBiotechnology

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$102.82M

EPS-1.2800

P/E Ratio-1.43

Earnings Date08/05/2026

seer

Shares Outstanding

Last Annual Value

57.45M

3-Year CAGR

-3%

5-Year CAGR

-1%

10-Year CAGR

10%

Adjust for Inflation

Seer, Inc. Competitors Analysis of shares-outstanding

SEER · NASDAQ

Company	shares-outstanding	CAGR 3Y	CAGR 5Y	CAGR 10Y
Seer, Inc. NASDAQ:SEER	57.45M	-3.5%	-1.1%	N/A
Foghorn Therapeutics Inc. NASDAQ:FHTX	62.98M	14.5%	11.1%	N/A
Kymera Therapeutics, Inc. NASDAQ:KYMR	84.39M	13.1%	12.0%	N/A
MediciNova, Inc. NASDAQ:MNOV	49.06M	0.0%	0.2%	4.0%
C4 Therapeutics, Inc. NASDAQ:CCCC	82.89M	18.6%	12.5%	N/A
AN2 Therapeutics, Inc. NASDAQ:ANTX	30.22M	8.6%	10.0%	N/A
Nkarta, Inc. NASDAQ:NKTX	73.99M	14.7%	17.6%	N/A
Nurix Therapeutics, Inc. NASDAQ:NRIX	86.67M	16.8%	15.1%	N/A
Mineralys Therapeutics, Inc. NASDAQ:MLYS	67.66M	23.2%	68.5%	N/A
Lyell Immunopharma, Inc. NASDAQ:LYEL	17.09M	10.8%	7.1%	N/A
Quantum-Si incorporated NASDAQ:QSI	197.76M	11.9%	20.0%	N/A

Seer, Inc. Fair Value Envelope

SEER · NASDAQ

Our analysis suggests that SEER has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.87, this represents a potential HIDDEN relative to our calculated worth for Seer, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.87

Related Guides

Blog Categories

Continue your SEER research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.